Yüklüyor......
Treatment of Experimental Choroidal Neovascularization via RUNX1 Inhibition
Choroidal neovascularization (CNV) is a prevalent cause of vision loss in patients with age-related macular degeneration. Runt-related transcription factor 1 (RUNX1) has been identified as an important mediator of aberrant retinal angiogenesis in proliferative diabetic retinopathy and its modulation...
Kaydedildi:
| Yayımlandı: | Am J Pathol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Investigative Pathology
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7931615/ https://ncbi.nlm.nih.gov/pubmed/33345998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2020.12.005 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|